(RTTNews) - Teva Pharmaceuticals USA is recalling specific lots of various strengths of FENTANYL Buccal Tablets CII to the consumer level citing a labeling error, the U.S. Food and Drug Administration ...
Credit: Teva Pharmaceuticals. Teva Pharmaceuticals is recalling certain lots of Fentanyl Buccal Tablets CII because safety updates were omitted in the product insert/medication guide. Teva ...
A manufacturing mistake in the production of fentanyl buccal tablets for Mayne Pharma has forced Teva to recall 13 lots of the product. (Teva) A labeling problem has forced Teva to recall 13 lots of ...
HONOLULU, HI—Patientswith chronic, noncancer-related pain who received fentanyl buccal tablet had consistent short-term efficacy acrossclinically meaningful analgesia measures, according to results of ...
Dara BioSciences ($DARA) is the new marketer of the only orally dissolving buccal tablet approved for oral thrush, which occurs when the Candida albicans fungus grows ...
Background and objectives: Patients with cancer, particularly those undergoing chemotherapy or radiotherapy, may develop oral mucositis. This is the first study to investigate the absorption profile ...
AUSTIN, TX—In a study presented at the American Pain Society’s 30th Annual Scientific Meeting, fentanyl buccal tablet (FBT) was shown to be more effective than traditional short-acting opioids (SAO) ...
This phase I, multicentre, open-label study was conducted in the US between April and September 2005. The two participating centres obtained Institutional Review Board approval and all patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results